CD68 and neoplasm: Notably, CD68+ TAMs predominantly localized to S15+ tumor cells demonstrated an adverse effect on prognosis (P = 0.026) (Fig. 6J), suggesting that S15+ tumor cells might enhance the immunosuppressive role of CD68+ TAMs.